Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

14.28
Delayed Data
As of Aug 28
 0.00 / 0.00%
Today’s Change
5.34
Today|||52-Week Range
19.43
+134.10%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Operating ActivitiesNet Income / Starting Line-73.3M-72.8M-71.4M-60.7M
 
 
 
 
 
Depreciation4.6M4.6M4.6M5.5M
 
 
 
 
 
Total Other Cash Flow9.4M12.4M29.2M15.9M
 
 
 
 
 
Funds From Operations-59.3M-55.7M-37.5M-39.4M
 
 
 
 
 
Funds From/For Other Operating Expenses-25.0M4.6M16.1M15.9M
 
 
 
 
 
Net Cash Flow - Operating Activities-34.3M-60.3M-53.7M-55.3M
 
 
 
 
 
 
InvestingCapital Expenditures-2.9M-3.8M-8.2M-7.4M
 
 
 
 
 
Other Investing - Uses-60.0K0.00-1.0K0.00
 
 
 
Other Investing - Sources0.0074.0K0.000.00
 
 
Net Cash Flow Investing-3.0M-3.7M-8.2M-7.4M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale7.0M98.0M9.1M4.4M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.00194.1M
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing7.0M98.0M9.1M198.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.000.000.00--
 
Net Change In Cash-30.3M34.0M-52.7M135.8M